Ad Code

Responsive Advertisement

Ticker

6/recent/ticker-posts

New immunotherapy platform has increased potential to target cancer cells

Researchers from Children's Hospital of Philadelphia (CHOP) and Stanford University have revealed the molecular structure of TRACeR-I, a protein platform for reprogramming immune responses.

from Medical Xpress - latest medical and health news stories https://ift.tt/sTeCKV2